Riyaz Bashir, TCT 2022: The Bashir endovascular catheter for pulmonary embolism
Mortality remains high in patients with high and intermediate risk pulmonary embolism (PE). The Bashir endovascular catheter device, designed for use in large vessels, aims to improve patient outcomes. In this touchCARDIO interview, we speak with Dr Riyaz Bashir (Temple University Hospital, Philadelphia, PA, USA) to discuss the unmet needs in PE and the Bashir endovascular catheter device.
The abstract entitled ‘A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis With the BASHIR™ Endovascular Catheter for Intermediate-Risk Acute Pulmonary Embolism – The RESCUE Study’ was presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 16 – 19, September 2022.
Questions:
- What are the unmet needs in the treatment of pulmonary embolism? (0:22)
- Could you give us a brief overview of the Bashir endovascular catheter? (1:36)
Disclosures: Riyaz Bashir is on the advisory board and speaker’s bureau for Thrombolex Inc. and a consultant for the company. He has received honorarium and grant/research support from Thrombolex Inc. and is a major stock shareholder.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of TCT 2022
Access more content on Devices here
